Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Magnetic resonance imaging head abnormal
Clinical narrative: mild stroke 40 days after second Moderna booster; He has tingling in his right hand and right foot.; This spontaneous case was reported by a patient and describes the occurrence of CEREBROVASCULAR ACCIDENT (mild stroke 40 days after second Moderna booster) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Patient had never tested positive for COVID.  Concurrent medical conditions included Seasonal allergy and Asthma.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jun-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CEREBROVASCULAR ACCIDENT (mild stroke 40 days after second Moderna booster) (seriousness criteria hospitalization and medically significant). In 2022, the patient experienced PARAESTHESIA (He has tingling in his right hand and right foot.). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN 81) for Stroke, at a dose of 81 milligram; CLOPIDOGREL BESYLATE (CLOPIDOGREL [CLOPIDOGREL BESYLATE]) for Stroke, at a dose of 75 milligram and ATORVASTATIN CALCIUM TRIHYDRATE (ATORVASTATIN [ATORVASTATIN CALCIUM TRIHYDRATE]) for Stroke, at a dose of 80 milligram. At the time of the report, CEREBROVASCULAR ACCIDENT (mild stroke 40 days after second Moderna booster) and PARAESTHESIA (He has tingling in his right hand and right foot.) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Patient went to emergency room on 10-Jun-2022. Patient had not experienced a similar event in the past.  Company comment: This spontaneous case concerns a 66 year old male patient, with no relevant medical history reported, who experienced the serious (hospitalization, medically significant), unexpected adverse event of special interest Cerebrovascular accident (mild stroke 40 days after second Moderna booster), which occurred 1 month, 20 days after the fourth dose of mRNA-1273 vaccine administration, which prompted the patient to go to the emergency room 1 day after. The outcome of the event was reported as resolving. The benefit -risk relationship of mRNA -1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 66 year old male patient, with no relevant medical history reported, who experienced the serious (hospitalization, medically significant), unexpected adverse event of special interest Cerebrovascular accident (mild stroke 40 days after second Moderna booster), which occurred 1 month, 20 days after the fourth dose of mRNA-1273 vaccine administration, which prompted the patient to go to the emergency room 1 day after. The outcome of the event was reported as resolving. The benefit -risk relationship of mRNA -1273 is not affected by this report.